ECCHER, SERENA
 Distribuzione geografica
Continente #
EU - Europa 211
AS - Asia 137
NA - Nord America 103
SA - Sud America 21
AF - Africa 8
Totale 480
Nazione #
RU - Federazione Russa 143
US - Stati Uniti d'America 98
SG - Singapore 66
IT - Italia 26
CN - Cina 20
BR - Brasile 18
VN - Vietnam 18
HK - Hong Kong 13
DE - Germania 11
GB - Regno Unito 11
FR - Francia 5
JP - Giappone 5
BJ - Benin 4
FI - Finlandia 4
CA - Canada 3
ID - Indonesia 3
KR - Corea 3
NL - Olanda 3
AT - Austria 2
BD - Bangladesh 2
EC - Ecuador 2
ES - Italia 2
IN - India 2
KE - Kenya 2
BE - Belgio 1
DO - Repubblica Dominicana 1
IL - Israele 1
IQ - Iraq 1
LT - Lituania 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
NP - Nepal 1
PL - Polonia 1
TG - Togo 1
TR - Turchia 1
UA - Ucraina 1
UY - Uruguay 1
Totale 480
Città #
Moscow 46
Singapore 28
Dallas 24
Ashburn 23
Hong Kong 13
Ho Chi Minh City 8
Munich 7
New York 7
Verona 7
Los Angeles 6
Naples 6
Tokyo 5
Cotonou 4
London 4
Hanoi 3
Helsinki 3
Milan 3
Padova 3
Redondo Beach 3
São Paulo 3
The Dalles 3
Anagni 2
Beijing 2
Biên Hòa 2
Brooklyn 2
Haiphong 2
Meda 2
Nairobi 2
Phoenix 2
Quanzhou 2
Stanford 2
Aizawl 1
Amsterdam 1
Augusta 1
Baghdad 1
Bauru 1
Brejões 1
Brussels 1
Buffalo 1
Bình Dương 1
Bắc Giang 1
Camaquã 1
Campinas 1
Castanhal 1
Charlotte 1
Chennai 1
Chicago 1
Cirebon 1
Denver 1
Dhaka 1
Duque de Caxias 1
Frankfurt am Main 1
Guayaquil 1
Hangzhou 1
Jakarta 1
Khulna 1
Lomé 1
Louisville 1
Maldonado 1
Montreal 1
Norfolk 1
Nova Timboteua 1
Nuremberg 1
Orem 1
Pitangueiras 1
Querétaro 1
Rach Gia 1
Rio de Janeiro 1
Sambir 1
San Francisco 1
Santa Clara 1
Santana da Vargem 1
Santo André 1
Santo Domingo 1
Semarang 1
Senador Firmino 1
Seoul 1
Toronto 1
Turku 1
Uruguaiana 1
Videira 1
Volta Redonda 1
Warsaw 1
Wolverhampton 1
Totale 282
Nome #
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 117
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 106
The frontier of neoadjuvant therapy in non-small cell lung cancer beyond PD-(L)1 agents 79
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 79
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab 59
Meta-Analysis Exploring Tyrosine Kinase Inhibitor-Induced Weight Gain in Oncogene-Addicted NSCLC 48
Totale 488
Categoria #
all - tutte 1.540
article - articoli 1.540
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.080


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20248 0 0 0 0 0 0 5 0 0 1 1 1
2024/2025122 11 1 10 23 5 4 5 1 19 0 9 34
2025/2026358 19 22 27 114 143 33 0 0 0 0 0 0
Totale 488